Combination of ribavirin and interferon‐alfa surpasses high doses of interferon‐alfa alone in patients with genotype‐1b–related chronic hepatitis C
Stanislas Pol, Bertrand Nalpas, Marc Bourlière, Patrice Couzigou, Albert Tran, Armand Abergel, Jean‐Pierre Zarski, Pierre Berthelot, Christian Bréchot – 30 December 2003 – The purpose of this study was to compare interferon‐alfa alone (12‐month course with high initial doses) with a combination of interferon‐alfa and ribavirin in patients infected with genotype 1b.